IndiaTickerLatest filing: Krebs Biochemicals & Industries Ltd-$ - 524518 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th Agust 2026
ObservedCompany dossier
Krebs Biochemicals & Industries
NSE:KREBSBIO · ISIN INE268B01013
- Close
- ₹54.04 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Krebs Biochemicals & Industries
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹11.5 Cr · PAT ₹-7.7 Cr.
Exchange XBRLLatest ownership: promoter group 72.74% and public 27.26% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Krebs Biochemicals & Industries Ltd-$ - 524518 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th Agust 2026
BSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Krebs Biochemicals and Industries Limited
NSE · exchange filing
Observed
Source filing Krebs Biochemicals & Industries Ltd-$ - 524518 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Outcome of Board Meeting - Krebs Biochemicals and Industries Limited
NSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹11.5 Cr
- Profit after tax
- ₹-7.7 Cr
- EPS
- ₹-3.59
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 72.74%
- Public
- 27.26%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL